These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


466 related items for PubMed ID: 16443508

  • 1. Catechol-O-methyltransferase polymorphism is associated with increased uterine leiomyoma risk in different ethnic groups.
    Al-Hendy A, Salama SA.
    J Soc Gynecol Investig; 2006 Feb; 13(2):136-44. PubMed ID: 16443508
    [Abstract] [Full Text] [Related]

  • 2. [Polymorphism of catechol-O-methyltransferase gene in relation to the risk of endometrial cancer].
    Zhao XM, Xie MQ, Yang DZ, Wang LA, Li SJ, Zhuang YY, Tang XL.
    Zhonghua Fu Chan Ke Za Zhi; 2007 Feb; 42(2):116-9. PubMed ID: 17442187
    [Abstract] [Full Text] [Related]

  • 3. Genetic susceptibility of catechol-O-methyltransferase polymorphism in Japanese patients with breast cancer.
    Inoue H, Shibuta K, Matsuyama A, Yoshinaga K, Sadanaga N, Ueo H, Barnard GF, Mori M.
    Oncol Rep; 2005 Sep; 14(3):707-12. PubMed ID: 16077979
    [Abstract] [Full Text] [Related]

  • 4. An association between the allele coding for a low activity variant of catechol-O-methyltransferase and the risk for breast cancer.
    Lavigne JA, Helzlsouer KJ, Huang HY, Strickland PT, Bell DA, Selmin O, Watson MA, Hoffman S, Comstock GW, Yager JD.
    Cancer Res; 1997 Dec 15; 57(24):5493-7. PubMed ID: 9407957
    [Abstract] [Full Text] [Related]

  • 5. Regulation of catechol O-methyltransferase expression in granulosa cells: a potential role for follicular arrest in polycystic ovary syndrome.
    Salih SM, Jamaluddin M, Salama SA, Fadl AA, Nagamani M, Al-Hendy A.
    Fertil Steril; 2008 May 15; 89(5 Suppl):1414-21. PubMed ID: 17612537
    [Abstract] [Full Text] [Related]

  • 6. The Val158Met polymorphism of the catechol-O-methyltransferase gene is associated with the PSA-progression-free survival in prostate cancer patients treated with estramustine phosphate.
    Suzuki M, Mamun MR, Hara K, Ozeki T, Yamada Y, Kadowaki T, Honda H, Yanagihara Y, Ito YM, Kameyama S, Ohta N, Hosoi T, Arai T, Sawabe M, Takeuchi T, Takahashi S, Kitamura T.
    Eur Urol; 2005 Nov 15; 48(5):752-9. PubMed ID: 16126332
    [Abstract] [Full Text] [Related]

  • 7. Polymorphism of catechol-o-methyltransferase and uterine leiomyoma.
    Ates O, Demirturk F, Toprak M, Sezer S.
    Mol Cell Biochem; 2013 Mar 15; 375(1-2):179-83. PubMed ID: 23238870
    [Abstract] [Full Text] [Related]

  • 8. High systolic blood pressure is associated with Val/Val genotype in the catechol-o-methyltransferase gene. The Nord-Trøndelag Health Study (HUNT).
    Hagen K, Pettersen E, Stovner LJ, Skorpen F, Holmen J, Zwart JA.
    Am J Hypertens; 2007 Jan 15; 20(1):21-6. PubMed ID: 17198907
    [Abstract] [Full Text] [Related]

  • 9. The associations between the Val158Met in the catechol-O-methyltransferase (COMT) gene and the risk of uterine leiomyoma (ULM).
    Feng Y, Zhao X, Zhou C, Yang L, Liu Y, Bian C, Gou J, Lin X, Wang Z, Zhao X.
    Gene; 2013 Oct 25; 529(2):296-9. PubMed ID: 23939469
    [Abstract] [Full Text] [Related]

  • 10. Catechol-O-methyltransferase polymorphism is not associated with ovarian cancer risk.
    Goodman JE, Lavigne JA, Hengstler JG, Tanner B, Helzlsouer KJ, Yager JD.
    Cancer Epidemiol Biomarkers Prev; 2000 Dec 25; 9(12):1373-6. PubMed ID: 11142424
    [Abstract] [Full Text] [Related]

  • 11. COMT gene Val158Met polymorphism influences the severity of intestinal metaplasia in H. pylori infected older subjects.
    Tahara T, Shibata T, Nakamura M, Yoshioka D, Okubo M, Maruyama N, Kamano T, Kamiya Y, Fujita H, Nagasaka M, Iwata M, Takahama K, Watanabe M, Yamashita H, Nakano H, Hirata I, Arisawa T.
    Hepatogastroenterology; 2009 Dec 25; 56(90):411-5. PubMed ID: 19579610
    [Abstract] [Full Text] [Related]

  • 12. Val158Met Polymorphism in catechol-O-methyltransferase gene associated with risk factors for breast cancer.
    Hong CC, Thompson HJ, Jiang C, Hammond GL, Tritchler D, Yaffe M, Boyd NF.
    Cancer Epidemiol Biomarkers Prev; 2003 Sep 25; 12(9):838-47. PubMed ID: 14504192
    [Abstract] [Full Text] [Related]

  • 13. [Prevalence of Val158Met polymorphism in COMT gene on non-BRCA1/2 hereditary breast cancer].
    Song CG, Hu Z, Yuan WT, Di GH, Shen ZZ, Huang W, Shao ZM.
    Zhonghua Wai Ke Za Zhi; 2006 Oct 01; 44(19):1310-3. PubMed ID: 17217814
    [Abstract] [Full Text] [Related]

  • 14. The Val158Met polymorphism of the human catechol-O-methyltransferase (COMT) gene may influence morphine requirements in cancer pain patients.
    Rakvåg TT, Klepstad P, Baar C, Kvam TM, Dale O, Kaasa S, Krokan HE, Skorpen F.
    Pain; 2005 Jul 01; 116(1-2):73-8. PubMed ID: 15927391
    [Abstract] [Full Text] [Related]

  • 15. Hormonal regulation of catechol-O-methyl transferase activity in women with uterine leiomyomas.
    Salama SA, Ho SL, Wang HQ, Tenhunen J, Tilgmann C, Al-Hendy A.
    Fertil Steril; 2006 Jul 01; 86(1):259-62. PubMed ID: 16730007
    [Abstract] [Full Text] [Related]

  • 16. Association between Val158Met functional polymorphism in the COMT gene and risk of preeclampsia in a Chinese population.
    Liang S, Liu X, Fan P, Liu R, Zhang J, He G, Liu Y, Bai H.
    Arch Med Res; 2012 Feb 01; 43(2):154-8. PubMed ID: 22475780
    [Abstract] [Full Text] [Related]

  • 17. Haplotype relative risk study of catechol-O-methyltransferase (COMT) and attention deficit hyperactivity disorder (ADHD): association of the high-enzyme activity Val allele with ADHD impulsive-hyperactive phenotype.
    Eisenberg J, Mei-Tal G, Steinberg A, Tartakovsky E, Zohar A, Gritsenko I, Nemanov L, Ebstein RP.
    Am J Med Genet; 1999 Oct 15; 88(5):497-502. PubMed ID: 10490706
    [Abstract] [Full Text] [Related]

  • 18. [Relation between single nucleotide polymorphism in estrogen-metabolizing genes COMT, CYP17 and breast cancer risk among Chinese women].
    Tan W, Qi J, Xing DY, Miao XP, Pan KF, Zhang L, Lin DX.
    Zhonghua Zhong Liu Za Zhi; 2003 Sep 15; 25(5):453-6. PubMed ID: 14575568
    [Abstract] [Full Text] [Related]

  • 19. The association of functional catechol-O-methyltransferase haplotypes with risk of Parkinson's disease, levodopa treatment response, and complications.
    Bialecka M, Kurzawski M, Klodowska-Duda G, Opala G, Tan EK, Drozdzik M.
    Pharmacogenet Genomics; 2008 Sep 15; 18(9):815-21. PubMed ID: 18698234
    [Abstract] [Full Text] [Related]

  • 20. The effects of catechol-O-methyltransferase inhibition on estrogen metabolite and oxidative DNA damage levels in estradiol-treated MCF-7 cells.
    Lavigne JA, Goodman JE, Fonong T, Odwin S, He P, Roberts DW, Yager JD.
    Cancer Res; 2001 Oct 15; 61(20):7488-94. PubMed ID: 11606384
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 24.